{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T13:12:55Z","timestamp":1777813975578,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R33AI102267"],"award-info":[{"award-number":["R33AI102267"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44092206"],"award-info":[{"award-number":["R44092206"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R43\/44 084225"],"award-info":[{"award-number":["R43\/44 084225"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R42AI069659"],"award-info":[{"award-number":["R42AI069659"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.antiviral.2019.104567","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T02:08:46Z","timestamp":1563934126000},"page":"104567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Polyphenylene carboxymethylene (PPCM) in vitro antiviral efficacy against Ebola virus in the context of a sexually transmitted infection"],"prefix":"10.1016","volume":"170","author":[{"given":"Olivier","family":"Escaffre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry L.","family":"Juelich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander N.","family":"Freiberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.antiviral.2019.104567_bib1","doi-asserted-by":"crossref","first-page":"S957","DOI":"10.1093\/infdis\/jir326","article-title":"Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis","volume":"204","author":"Aleksandrowicz","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104567_bib2","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1128\/JVI.76.13.6841-6844.2002","article-title":"C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans","volume":"76","author":"Alvarez","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104567_bib3","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.4049\/jimmunol.180.4.2474","article-title":"An important role for type III interferon (IFN-lambda\/IL-28) in TLR-induced antiviral activity","volume":"180","author":"Ank","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104567_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/jir.2013.0035","article-title":"Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways","volume":"34","author":"Ayithan","year":"2014","journal-title":"J. Interferon Cytokine Res. : Off. J. Int. Soc. Inter. Cytokine Res."},{"key":"10.1016\/j.antiviral.2019.104567_bib5","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/cid\/cix518","article-title":"Evidence of ebola virus replication and high concentration in semen of a patient during recovery","volume":"65","author":"Barnes","year":"2017","journal-title":"Clin. Infect. Dis. : Off. Publ. Infect. Dis. Soc. Am."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2019.104567_bib6","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1086\/520545","article-title":"Assessment of the risk of Ebola virus transmission from bodily fluids and fomites","volume":"196","author":"Bausch","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104567_bib7","doi-asserted-by":"crossref","first-page":"41029","DOI":"10.1038\/srep41029","article-title":"Broad-range antiviral activity of hydrogen sulfide against highly pathogenic RNA viruses","volume":"7","author":"Bazhanov","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104567_bib8","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","article-title":"CellProfiler: image analysis software for identifying and quantifying cell phenotypes","volume":"7","author":"Carpenter","year":"2006","journal-title":"Genome Biol."},{"key":"10.1016\/j.antiviral.2019.104567_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ajpath.2013.10.005","article-title":"HCV infection selectively impairs type I but not type III IFN signaling","volume":"184","author":"Chandra","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2019.104567_bib10","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1016\/j.febslet.2007.08.048","article-title":"SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell-mediated HIV transmission","volume":"581","author":"Chang","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2019.104567_bib11","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm0897-866","article-title":"Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate","volume":"3","author":"Chen","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2019.104567_bib12","first-page":"479","article-title":"Possible sexual transmission of Ebola virus - Liberia, 2015","volume":"64","author":"Christie","year":"2015","journal-title":"MMWR. Morb. Mort. Weekly Rep."},{"key":"10.1016\/j.antiviral.2019.104567_bib13","first-page":"271","article-title":"Ebola haemorrhagic fever in Zaire, 1976","volume":"56","author":"Commission","year":"1978","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2019.104567_bib14","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/infdis\/jiw079","article-title":"Ebola virus RNA in the semen of male survivors of ebola virus disease: the uncertain gravitas of a privileged persistence","volume":"214","author":"Crozier","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104567_bib15","doi-asserted-by":"crossref","first-page":"13767","DOI":"10.1128\/JVI.01364-12","article-title":"Heparan sulfate facilitates Rift Valley fever virus entry into the cell","volume":"86","author":"de Boer","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104567_bib16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJMoa1511410","article-title":"Ebola RNA persistence in semen of ebola virus disease survivors - final report","volume":"377","author":"Deen","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.104567_bib17","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3389\/fimmu.2018.01803","article-title":"Advances in designing and developing vaccines, drugs, and therapies to counter ebola virus","volume":"9","author":"Dhama","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2019.104567_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/bs.aivir.2017.12.002","article-title":"Filoviruses: ecology, molecular biology, and evolution","volume":"100","author":"Emanuel","year":"2018","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2019.104567_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.2.6086.541","article-title":"A case of Ebola virus infection","volume":"2","author":"Emond","year":"1977","journal-title":"Br. Med. J."},{"key":"10.1016\/j.antiviral.2019.104567_bib20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1473-3099(16)30516-3","article-title":"Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study","volume":"17","author":"Etard","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104567_bib21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.104567_bib22","article-title":"Filoviridae: marburg and ebola viruses","volume":"vol 1","author":"Feldmann","year":"2013"},{"key":"10.1016\/j.antiviral.2019.104567_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx155","article-title":"Ebola virus ribonucleic acid detection in semen more than two years after resolution of acute ebola virus infection","volume":"4","author":"Fischer","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104567_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.104567_bib25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2019.104567_bib26","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1093\/infdis\/jiv209","article-title":"Development and characterization of broadly cross-reactive monoclonal antibodies against all known Ebolavirus species","volume":"212","author":"Hernandez","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104567_bib27","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1128\/JVI.76.22.11236-11244.2002","article-title":"Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry","volume":"76","author":"Herold","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104567_bib28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cmi.2016.11.005","article-title":"Extraordinary long-term and fluctuating persistence of Ebola virus RNA in semen of survivors in Guinea: implications for public health","volume":"23","author":"Keita","year":"2017","journal-title":"Clin. Microbiol. Infect. : Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104567_bib29","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1128\/JVI.01362-16","article-title":"Inhibition of human metapneumovirus binding to heparan sulfate blocks infection in human lung cells and airway tissues","volume":"90","author":"Klimyte","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104567_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0042-6822(02)00097-1","article-title":"Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus","volume":"308","author":"Kroschewski","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104567_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2144\/000112257","article-title":"CellProfiler: free, versatile software for automated biological image analysis","volume":"42","author":"Lamprecht","year":"2007","journal-title":"Biotechniques"},{"key":"10.1016\/j.antiviral.2019.104567_bib32","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41598-018-38397-3","article-title":"Effect of sexual transmission on the West Africa Ebola outbreak in 2014: a mathematical modelling study","volume":"9","author":"Luo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104567_bib33","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s40262-015-0364-1","article-title":"Ebola virus infection: review of the pharmacokinetic and pharmacodynamic properties of drugs considered for testing in human efficacy trials","volume":"55","author":"Madelain","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2019.104567_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.trivac.2014.04.002","article-title":"Novel neutralizing monoclonal antibodies protect rodents against lethal filovirus challenges","volume":"3","author":"Marceau","year":"2014","journal-title":"Trials Vaccinol."},{"key":"10.1016\/j.antiviral.2019.104567_bib35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.virol.2007.03.020","article-title":"Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain","volume":"364","author":"Martinez","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104567_bib36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF01734141","article-title":"[Spermatogenic transmission of the \"Marburg virus\". (Causes of \"Marburg simian disease\")]","volume":"46","author":"Martini","year":"1968","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.antiviral.2019.104567_bib37","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1509773","article-title":"Molecular evidence of sexual transmission of ebola virus","volume":"373","author":"Mate","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.104567_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004731","article-title":"Ebola virus entry: a curious and complex series of events","volume":"11","author":"Moller-Tank","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104567_bib39","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JVI.72.5.3623-3634.1998","article-title":"Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans","volume":"72","author":"Mondor","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104567_bib40","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1128\/CVI.00170-10","article-title":"Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies","volume":"17","author":"Nakayama","year":"2010","journal-title":"Clin. Vaccine Immunol. : CVI"},{"key":"10.1016\/j.antiviral.2019.104567_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001121","article-title":"Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner","volume":"6","author":"Nanbo","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104567_bib42","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1128\/JVI.03689-14","article-title":"Role of EXT1 and glycosaminoglycans in the early stage of filovirus entry","volume":"89","author":"O'Hearn","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104567_bib43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ni.2915","article-title":"Diverse intracellular pathogens activate type III interferon expression from peroxisomes","volume":"15","author":"Odendall","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2019.104567_bib44","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1348-0421.1996.tb01148.x","article-title":"Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection","volume":"40","author":"Ohshiro","year":"1996","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2019.104567_bib45","first-page":"293","article-title":"Filovirus strategies to escape antiviral responses","volume":"411","author":"Olejnik","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2019.104567_bib46","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1128\/JVI.00996-15","article-title":"Human and murine IFIT1 proteins do not restrict infection of negative-sense RNA viruses of the orthomyxoviridae, bunyaviridae, and Filoviridae families","volume":"89","author":"Pinto","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104567_bib47","doi-asserted-by":"crossref","first-page":"963","DOI":"10.15585\/mmwr.mm6536a5","article-title":"Implementation of a national semen testing and counseling program for male ebola survivors - Liberia, 2015-2016","volume":"65","author":"Purpura","year":"2016","journal-title":"MMWR. Morb. Mort. Weekly Rep."},{"key":"10.1016\/j.antiviral.2019.104567_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005263","article-title":"Interferon-gamma inhibits ebola virus infection","volume":"11","author":"Rhein","year":"2015","journal-title":"PLoS Pathog."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.104567_bib49","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1086\/514291","article-title":"Persistence and genetic stability of ebola virus during the outbreak in kikwit, democratic republic of the Congo, 1995","volume":"179","author":"Rodriguez","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.104567_bib50","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/514318","article-title":"Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit","volume":"179","author":"Rowe","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104567_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001110","article-title":"Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes","volume":"6","author":"Saeed","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104567_bib52","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1128\/JVI.01621-12","article-title":"Filoviruses utilize glycosaminoglycans for their attachment to target cells","volume":"87","author":"Salvador","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104567_bib53","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1083\/jcb.116.5.1273","article-title":"Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans","volume":"116","author":"Shieh","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2019.104567_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/viro.2002.1730","article-title":"DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells","volume":"305","author":"Simmons","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104567_bib55","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S2214-109X(16)30243-1","article-title":"Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study","volume":"5","author":"Sissoko","year":"2017","journal-title":"Lancet Global health"},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2019.104567_bib56","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1086\/520551","article-title":"Forty years of marburg virus","volume":"196","author":"Slenczka","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104567_bib57","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.1016\/S2214-109X(16)30175-9","article-title":"Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data","volume":"4","author":"Soka","year":"2016","journal-title":"Lancet Global health"},{"key":"10.1016\/j.antiviral.2019.104567_bib58","doi-asserted-by":"crossref","first-page":"9140","DOI":"10.1128\/JVI.00717-10","article-title":"Alpha\/beta interferon (IFN-alpha\/beta)-independent induction of IFN-lambda 1 (interleukin-29) in response to Hantaan virus infection","volume":"84","author":"Stoltz","year":"2010","journal-title":"J. Virol."},{"issue":"suppl_5","key":"10.1016\/j.antiviral.2019.104567_bib59","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1093\/infdis\/jiy280","article-title":"Ebola virus transmission caused by persistently infected survivors of the 2014-2016 outbreak in West Africa","volume":"218","author":"Subissi","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104567_bib60","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/cid\/cix210","article-title":"Dynamics of ebola RNA persistence in semen: a report from the postebogui cohort in Guinea","volume":"64","author":"Subtil","year":"2017","journal-title":"Clin. Infect. Dis. : Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.antiviral.2019.104567_bib61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12985-018-1045-0","article-title":"Heparan sulfate is an important mediator of Ebola virus infection in polarized epithelial cells","volume":"15","author":"Tamhankar","year":"2018","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2019.104567_bib62","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4269\/ajtmh.2010.09-0636","article-title":"Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses","volume":"82","author":"Trombley","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2019.104567_bib63","series-title":"Interim Advice on the Sexual Transmission of the Ebola Virus Disease","author":"WHO","year":"2016"},{"key":"10.1016\/j.antiviral.2019.104567_bib64","author":"WHO"},{"key":"10.1016\/j.antiviral.2019.104567_bib65","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/JVI.72.4.3155-3160.1998","article-title":"Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines","volume":"72","author":"Wool-Lewis","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104567_bib66","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0015-0282(02)04210-3","article-title":"Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxis","volume":"78","author":"Zaneveld","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.antiviral.2019.104567_bib67","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.4049\/jimmunol.1003389","article-title":"Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN","volume":"186","author":"Zhang","year":"2011","journal-title":"J. Immunol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421930230X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421930230X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:11:19Z","timestamp":1777497079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421930230X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":67,"alternative-id":["S016635421930230X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104567","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyphenylene carboxymethylene (PPCM) in vitro antiviral efficacy against Ebola virus in the context of a sexually transmitted infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104567"}}